Company Filing History:
Years Active: 2024
Title: Richard Chamberlin: Innovator in Cancer Treatment
Introduction
Richard Chamberlin is a notable inventor based in Irvine, California, recognized for his contributions to cancer treatment through innovative research. He has developed a patent that focuses on APE/REF1 inhibitors, which play a crucial role in the treatment of cancer.
Latest Patents
Chamberlin holds a patent for APE/REF1 inhibitors for the treatment of cancer. This patent details the use of Apurinic/apyrimidinic endonuclease 1/Redox Factor-1 (APE/Ref-1) inhibitors, along with methods for their application. The structure of the inhibitor is defined by Formula I, where 'n' is an integer ranging from 4 to 14, and both 'X' and 'X'' can be either H or OH. Additionally, 'Y' and 'Y′' are also independently H or OH, providing a versatile approach to cancer treatment.
Career Highlights
Throughout his career, Richard Chamberlin has worked with prestigious institutions such as Chapman University and the University of California. His work has significantly impacted the field of cancer research, showcasing his dedication to advancing medical science.
Collaborations
Chamberlin has collaborated with notable colleagues, including Sun Yang and Keykavous Parang, further enhancing the scope and impact of his research.
Conclusion
Richard Chamberlin's innovative work in developing APE/REF1 inhibitors marks a significant advancement in cancer treatment. His contributions reflect a commitment to improving healthcare through scientific research and collaboration.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.